Paper24907149
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.
Choy E and 4 others. Rheumatology (Oxford), 2014. Cited by 244 papers, by iCite.
Cite this record
ConductScience Library. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Papers, record 24907149. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24907149
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Cardiovascular Diseases | Major topic |
| Inflammation | Major topic |
| Antirheumatic Agents | |
| Biological Products | |
| Humans | |
| Lipids | |
| Risk Factors | |
| Tumor Necrosis Factor-alpha |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT03960515 | Cardiovascular Profiles in Rheumatoid Arthritis | Background | ClinicalTrials.gov | |
| NCT05938244 | Cardiac and Pulmonary Assessment in Egyptian Patients With Rheumatoid Arthritis | Background | ClinicalTrials.gov |
References148
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24368514 | Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study. | Ann Rheum Dis | 2015 | https://conductscience.org/library/papers/24368514 | PubMed |
| 2 | 21360490 | Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year. | Arthritis Rheum | 2011 | https://conductscience.org/library/papers/21360490 | PubMed |
| 3 | 20110520 | Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials. | J Rheumatol | 2010 | https://conductscience.org/library/papers/20110520 | PubMed |
| 4 | 12943870 | Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). | Am J Cardiol | 2003 | https://conductscience.org/library/papers/12943870 | PubMed |
| 5 | 12485966 | Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. | Circulation | 2002 | https://conductscience.org/library/papers/12485966 | PubMed |
| 6 | 23589412 | Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients. | Arthritis Care Res (Hoboken) | 2013 | https://conductscience.org/library/papers/23589412 | PubMed |
| 7 | 21843325 | Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. | Arthritis Res Ther | 2011 | https://conductscience.org/library/papers/21843325 | PubMed |
| 8 | 20551156 | Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. | Ann Rheum Dis | 2010 | https://conductscience.org/library/papers/20551156 | PubMed |
| 9 | 22873531 | Tofacitinib or adalimumab versus placebo in rheumatoid arthritis. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22873531 | PubMed |
| 10 | 19946022 | The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. | Rheumatology (Oxford) | 2010 | https://conductscience.org/library/papers/19946022 | PubMed |
| 11 | 23515142 | Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial. | Lancet | 2013 | https://conductscience.org/library/papers/23515142 | PubMed |
| 12 | 15742433 | Prediction of mortality in rheumatoid arthritis based on disease activity markers. | J Rheumatol | 2005 | https://conductscience.org/library/papers/15742433 | PubMed |
| 13 | 18358926 | Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. | Lancet | 2008 | https://conductscience.org/library/papers/18358926 | PubMed |
| 14 | 21884601 | Integrated safety in tocilizumab clinical trials. | Arthritis Res Ther | 2011 | https://conductscience.org/library/papers/21884601 | PubMed |
| 15 | 19877093 | Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. | Arthritis Rheum | 2009 | https://conductscience.org/library/papers/19877093 | PubMed |
| 16 | 19430165 | Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis. | Circ J | 2009 | https://conductscience.org/library/papers/19430165 | PubMed |
| 17 | 19858120 | Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: a dose-response relationship independent of established cardiovascular risk factors. | Rheumatology (Oxford) | 2009 | https://conductscience.org/library/papers/19858120 | PubMed |
| 18 | 12628952 | Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. | Circulation | 2003 | https://conductscience.org/library/papers/12628952 | PubMed |
| 19 | 19035419 | Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. | Arthritis Rheum | 2008 | https://conductscience.org/library/papers/19035419 | PubMed |
| 20 | 20957658 | Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis. | Arthritis Care Res (Hoboken) | 2011 | https://conductscience.org/library/papers/20957658 | PubMed |
Cited by160
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 244 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42835576 | Autoimmune disorders and cardiovascular disease: a matched cross-sectional analysis of disease-specific associations in Qatari primary care. | Am Heart J Plus | 2026 | https://conductscience.org/library/papers/42835576 | PubMed |
| 42774336 | JAK inhibitors and adverse cardiovascular events: Class effect or molecule-specific risk? | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42774336 | PubMed |
| 42684557 | Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational "real-life" GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study. | Clin Rheumatol | 2026 | https://conductscience.org/library/papers/42684557 | PubMed |
| 42683195 | Role of Cardiac Imaging in the Evaluation of Rheumatoid Arthiritis: A Systematic Analysis. | Cureus | 2026 | https://conductscience.org/library/papers/42683195 | PubMed |
| 42452709 | Comorbidity Profiles at Diagnosis in Rheumatoid Arthritis Versus Psoriatic Arthritis: A Nationwide Polish Claims-Based Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/42452709 | PubMed |
| 42327968 | Oxidized High-Density Lipoprotein and Cardiovascular Risk in Rheumatoid Arthritis. | J Clin Med Res | 2026 | https://conductscience.org/library/papers/42327968 | PubMed |
| 42298194 | Diagnostic, prognostic and therapeutic biomarkers in rheumatoid arthritis. | Nat Rev Rheumatol | 2026 | https://conductscience.org/library/papers/42298194 | PubMed |
| 42291085 | Effect of IL-6 inhibition on lipoprotein(a) levels: A systematic review and meta-analysis. | Am J Prev Cardiol | 2026 | https://conductscience.org/library/papers/42291085 | PubMed |
| 42110040 | Janus Kinase and Interleukin-6 Inhibitor-Induced Lipid Modulation and Its Association With Major Adverse Cardiovascular Events in Rheumatoid Arthritis: A Systematic Review of Clinical and Biomarker Evidence. | Cureus | 2026 | https://conductscience.org/library/papers/42110040 | PubMed |
| 41727944 | Cardiovascular Disease and Risk Factors among Patients with Rheumatoid Arthritis in a Tertiary Government Hospital in the Philippines. | Acta Med Philipp | 2026 | https://conductscience.org/library/papers/41727944 | PubMed |
| 41346979 | Development and validation of an interpretable machine learning model for predicting low muscle mass in patients with rheumatoid arthritis: a multicenter study. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41346979 | PubMed |
| 40943434 | Post-Translational Modifications of Lipoproteins: Emerging Players Linking Inflammation and Cardiovascular Disease in Rheumatoid Arthritis-A Narrative Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943434 | PubMed |
| 40918183 | Subclinical myocardial changes in rheumatoid arthritis: cardiovascular magnetic resonance evidence of immuno-inflammatory remodeling. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40918183 | PubMed |
| 40794325 | Serum metabolomics identifies unique inflammatory signatures to distinguish rheumatoid arthritis responders and non-responders to TNF inhibitor therapy. | Metabolomics | 2025 | https://conductscience.org/library/papers/40794325 | PubMed |
| 40727925 | Soluble interleukin-33 receptor (sST-2): a novel marker for assessing cardiovascular risk in rheumatoid arthritis. | J Circ Biomark | 2025 | https://conductscience.org/library/papers/40727925 | PubMed |
| 40700294 | Survival Outcomes and Prognostic Factors in Rheumatoid Arthritis Patients Receiving Biologic or Targeted Synthetic Therapy: Real-World Data. | Antibodies (Basel) | 2025 | https://conductscience.org/library/papers/40700294 | PubMed |
| 40490834 | The impact of lifestyle modification on metabolic pathways in older adults with overweight/obesity and rheumatoid arthritis: a secondary exploratory analysis of the SWET-RA study. | BMC Rheumatol | 2025 | https://conductscience.org/library/papers/40490834 | PubMed |
| 40436519 | IL-6 Inhibitors and TNF Inhibitors: Impact on Exercise-induced Cardiac Adaptations in Patients With Rheumatoid Arthritis. | JACC Basic Transl Sci | 2025 | https://conductscience.org/library/papers/40436519 | PubMed |
| 40283183 | From Joints to the Heart: An Integrated Perspective on Systemic Inflammation. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40283183 | PubMed |
| 40221560 | Clinical significance of the hemoglobin-to-red blood cell distribution width ratio in patients with severe OSAS. | Sci Rep | 2025 | https://conductscience.org/library/papers/40221560 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24907149
GET https://conductscience.org/api/papers/v1/24907149/references?page=2